The relationship between cancer and sporadic Parkinson's disease (PD) has recently come under scrutiny based on common epidemiological (e.g., smoking, pesticide, estrogen exposure) and genetic (e.g., CYP2D6 alleles) factors, which suggest convergent mechanisms. This evidence concerns the gene CYP2D6 and Parkinson disease.